Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Discovery of novel bergenin derivatives as immunosuppressive agents

Jan. 7, 2022

Pfizer and BioNTech collaborate on mRNA-based vaccine to prevent shingles

Jan. 7, 2022

Hemagglutinin anchor epitope unveiled as a target of broadly neutralizing antibodies

Jan. 7, 2022

Tonix and Kansas State enter option agreement and research collaboration on LNP-free mRNA vaccines

Jan. 5, 2022

Novel covalent BTK inhibitor with good potency and reduced CYP inhibitory activity

Jan. 5, 2022

Aridis' AR-701 is broadly reactive against Omicron and other SARS-CoV-2 variants

Dec. 21, 2021

Genexine presents fusion proteins for treating immune diseases

Dec. 15, 2021

Q32 Bio presents preclinical data on ADX-097 from innate immunity program

Dec. 13, 2021

GreenLight and IAVI partner on mRNA vaccine candidate for SARS-CoV-2 Omicron variant

Dec. 7, 2021

Kaleido and Janssen expand Microbiome Metabolic Therapies collaboration

Dec. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...